相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
E. Antonio Chiocca et al.
NEURO-ONCOLOGY (2019)
Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance
Ourania N. Kostopoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma
J. Duerinck et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma
Jacob J. Mandel et al.
NEURO-ONCOLOGY (2018)
Tumor-treating fields as a fourth treating modality for glioblastoma: a meta-analysis
Dimitrios E. Magouliotis et al.
ACTA NEUROCHIRURGICA (2018)
Bevacizumab plus nypofractionated raciotnerapy versus radiotherapy alone in elderly patients with glioblastoma: tie randomized, open-label, phase II ARTE trial
H-G. Wirsching et al.
ANNALS OF ONCOLOGY (2018)
Relationship between the extent of resection and the survival of patients with low-grade gliomas: a systematic review and meta-analysis
Liang Xia et al.
BMC CANCER (2018)
CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?
Brooke L. Prinzing et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Highlighting the need for reliable clinical trials in glioblastoma
Jacob J. Mandel et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma
Soumon Rudra et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Translational gap in ongoing clinical trials for glioma
Alecia Florence Guishard et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Ten-year survival in glioblastoma. A systematic review
Tomasz Tykocki et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC
Timothy F. Cloughesy et al.
NEURO-ONCOLOGY (2018)
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
Alyssa M. Vanderbeek et al.
NEURO-ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Therapeutic efficacy of specific immunotherapy for glioma: a systematic review and meta-analysis
Sara Hanaei et al.
REVIEWS IN THE NEUROSCIENCES (2018)
Effectiveness of lomustine and bevacizumab in progressive glioblastoma: a meta-analysis
Jie Song et al.
ONCOTARGETS AND THERAPY (2018)
Results of a Policy of Fast Tapering of Steroids After Resection Surgery in Glioblastoma
Ricardo Diez Valle et al.
WORLD NEUROSURGERY (2018)
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
Serena Pellegatta et al.
ONCOIMMUNOLOGY (2018)
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
Yu Yao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Bevacizumab and Glioblastoma Past, Present, and Future Directions
Michelle M. Kim et al.
CANCER JOURNAL (2018)
A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy
Aleksei A. Stepanenko et al.
GENE (2018)
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
Joshua D. Palmer et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
Martin J. van den Bent et al.
LANCET ONCOLOGY (2018)
First results on the DCVax phase III trial: raising more questions than providing answers
Wolfgang Wick et al.
NEURO-ONCOLOGY (2018)
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX
Aleksei A. Stepanenko et al.
VIRUS RESEARCH (2018)
Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials
Stefan-Alexandru Artene et al.
SCIENTIFIC REPORTS (2018)
Immunotherapy in Glioblastoma
Jessica A. Wilcox et al.
WORLD NEUROSURGERY (2018)
Bevacizumab combined with chemotherapy vs single-agent therapy in recurrent glioblastoma: evidence from randomized controlled trials
Zhouqing Chen et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
Ibrahim Ragab Eissa et al.
CANCERS (2018)
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial
Johanna Buchroithner et al.
CANCERS (2018)
Radiotherapy of glioblastoma 15 years after the landmark Stupp's trial: more controversies than standards?
Tomas Kazda et al.
RADIOLOGY AND ONCOLOGY (2018)
Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial
Nan Ji et al.
JCI INSIGHT (2018)
Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
Susannah G. Ellsworth
ADVANCES IN RADIATION ONCOLOGY (2018)
Effect of valproic acid on survival in glioblastoma: A prospective single-arm study
Deepthi Valiyaveettil et al.
SOUTH ASIAN JOURNAL OF CANCER (2018)
CART-Cell Therapies in Glioblastoma: A First Look
Denis Migliorini et al.
CLINICAL CANCER RESEARCH (2018)
The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
Xiaozhu Li et al.
CLINICAL CANCER RESEARCH (2017)
Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma
Shinichi Watanabe et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
Doo-Sik Kong et al.
ONCOTARGET (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: An analysis of the literature
Matthew Tipping et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
The use of isoflurane and desflurane as inhalational agents for glioblastoma surgery. A survival analysis
J. P. Cata et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Immune checkpoint inhibitors in malignancies with mismatch repair deficiency: a review of the state of the current knowledge
Ali Naboush et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2017)
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
Myra E. van Linde et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Susana Inoges et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited
Huy Tram N. Nguyen et al.
LANCET ONCOLOGY (2017)
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited Reply
Michael Weller et al.
LANCET ONCOLOGY (2017)
Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients A single-center analysis
Tae Hoon Roh et al.
MEDICINE (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Deborah T. Blumenthal et al.
NEURO-ONCOLOGY (2017)
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
Tiffany R. Hodges et al.
NEURO-ONCOLOGY (2017)
RANDOMIZED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE 143
D. A. Reardona et al.
NEURO-ONCOLOGY (2017)
Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma
Dorothee Gramatzki et al.
NEUROLOGY (2017)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma
Marco Skardelly et al.
ONCOLOGIST (2017)
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov
Nikola Cihoric et al.
RADIATION ONCOLOGY (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
Pengju Wang et al.
NATURE COMMUNICATIONS (2017)
DNA Damage and Repair Biomarkers of Immunotherapy Response
Kent W. Mouw et al.
CANCER DISCOVERY (2017)
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
Christophe Massard et al.
CANCER DISCOVERY (2017)
Efficacy and safety of long-term therapy for high-grade glioma with temozolomide: A meta-analysis
Weilin Xu et al.
ONCOTARGET (2017)
Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
Anna C. Filley et al.
ONCOTARGET (2017)
Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme
Giannis Sokratous et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
Giulia Viale et al.
BIOMED RESEARCH INTERNATIONAL (2017)
In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2017)
The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity
Anne Kleijn et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Individualized screening trial of innovative glioblastoma therapy (INSIGhT).
Brian Michael Alexander et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Expanded phase I study of intratumoral Ad-RTS-hIL-12 plus oral veledimex: Tolerability and survival in recurrent glioblastoma.
E. Antonio Chiocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives
Ping Zhu et al.
CHINESE CLINICAL ONCOLOGY (2017)
Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy
Orin Bloch et al.
CLINICAL CANCER RESEARCH (2017)
Phase 1b open-label randomized study of the oncolytic adenovirus DNX-2401 administered with or without interferon gamma for recurrent glioblastoma.
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Kristen A. Batich et al.
CLINICAL CANCER RESEARCH (2017)
Immune regulation by glucocorticoids
Derek W. Cain et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Clinical Relevance of Steroid Use in Neuro-Oncology
K. Ina Ly et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients
M. Mehta et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials
Giuseppe Lombardi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Prognostic relevance of epilepsy at presentation in glioblastoma patients
Sharon Berendsen et al.
NEURO-ONCOLOGY (2016)
Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies
Alistair M. Cook et al.
ONCOIMMUNOLOGY (2016)
Corticosteroids compromise survival in glioblastoma
Kenneth L. Pitter et al.
BRAIN (2016)
Therapeutic options in recurrent glioblastoma-An update
Katharina Seystahl et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
A critical balance: managing coagulation in patients with glioma
Erin R. Morgan et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Chemoradiation-Related Lymphopenia Is Common Among Glioblastoma Patients and Is Associated With Worse Progression-Free and Overall Survival
R. Rahman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
What Happens When Underperforming Big Ideas in Research Become Entrenched?
Michael J. Joyner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Venous thromboembolism in brain tumor patients
David J. Cote et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
Caroline Happold et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide
Navid Redjal et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Does the choice of antiepileptic drug affect survival in glioblastoma patients?
Kristin M. Knudsen-Baas et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma
Joe S. Mendez et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
The precision-oncology illusion
Vinay Prasad
NATURE (2016)
Limits to Personalized Cancer Medicine
Ian F. Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review
Jiahao Su et al.
ONCOLOGY RESEARCH (2016)
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
Abhishek D. Garg et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Recurrent venous thromboembolism in glioblastoma
Natasha Catherine Edwin et al.
THROMBOSIS RESEARCH (2016)
Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review
Lynn S. Ashby et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
Tanner M. Johanns et al.
CANCER DISCOVERY (2016)
A critical balance: managing coagulation in patients with glioma
Erin R. Morgan et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination
Melody S. Hsu et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
E. T. Wong et al.
BRITISH JOURNAL OF CANCER (2015)
Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme
Young-Hoon Kim et al.
CANCER (2015)
Prognostic implications of epilepsy in glioblastomas
Manuel Toledo et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2015)
Venous thrombosis in patients with high-grade glioma
Sophie Taillibert et al.
CURRENT OPINION IN ONCOLOGY (2015)
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
Manfred Westphal et al.
EUROPEAN JOURNAL OF CANCER (2015)
Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
Minh Thi Tieu et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival
Marcos A. dos Santos et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Heparin in malignant glioma: review of preclinical studies and clinical results
Rosalie Schnoor et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors
Michael B. Streiff et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
Sajeel A. Chowdhary et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau et al.
LANCET ONCOLOGY (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
David A. Reardon et al.
NEURO-ONCOLOGY (2015)
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
James Schuster et al.
NEURO-ONCOLOGY (2015)
Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis
Saleh A. Almenawer et al.
NEURO-ONCOLOGY (2015)
Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients
Lisa B. E. Shields et al.
RADIATION ONCOLOGY (2015)
The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis
Wei-kang Xing et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
Carolien A. Koks et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Tumor selectivity of oncolytic parvoviruses: from in vitro and animal models to cancer patients
Assia L. Angelova et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2015)
Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review
Xuan Wang et al.
CANCER INVESTIGATION (2014)
A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma
Wolfgang Wick et al.
CLINICAL CANCER RESEARCH (2014)
Hypofractionated stereotactic reirradiation for recurrent glioblastoma
Gozde Yazici et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Seizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management
Charles J. Vecht et al.
ONCOLOGIST (2014)
Clinical Efficacy of Tumor Antigen-Pulsed DC Treatment for High-Grade Glioma Patients: Evidence from a Meta-Analysis
Jun-Xia Cao et al.
PLOS ONE (2014)
Survival analysis for valproic acid use in adult glioblastoma multiforme: A meta-analysis of individual patient data and a systematic review
Yang Yuan et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2014)
Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy
Sadhak Sengupta et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide
Susannah Ellsworth et al.
ONCOIMMUNOLOGY (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution
Signe Regner Michaelsen et al.
BMC CANCER (2013)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Einar Osland Vik-Mo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
Sara Fritzell et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells
Susannah Yovino et al.
CANCER INVESTIGATION (2013)
Survival of children with malignant brain tumors receiving valproate: a retrospective study
F. H. C. Felix et al.
CHILDS NERVOUS SYSTEM (2013)
Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: A clinical audit
Tejpal Gupta et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas
Filip Y. De Vos et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
The treatment of glioblastomas: A systematic update on clinical Phase III trials
An-an Yin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
The role of Gliadel wafers in the treatment of high-grade gliomas
Amade Bregy et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival
Christopher A. Barker et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Steroid management in newly diagnosed glioblastoma
Mariel B. Deutsch et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme Clinical article
Greg D. Guthrie et al.
JOURNAL OF NEUROSURGERY (2013)
Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme
Melissa Kerkhof et al.
NEURO-ONCOLOGY (2013)
Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
Patrizia Ciammella et al.
RADIATION ONCOLOGY (2013)
Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment
Jordi Bruna et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Effect of valproic acid on the outcome of glioblastoma multiforme
Hong-Chieh Tsai et al.
BRITISH JOURNAL OF NEUROSURGERY (2012)
Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries
Amy S. Darefsky et al.
CANCER (2012)
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Hilko Ardon et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
X. Jie et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
Sadhak Sengupta et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity
James R. Tysome et al.
CLINICAL CANCER RESEARCH (2012)
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp et al.
EUROPEAN JOURNAL OF CANCER (2012)
Polymer Wafers (Gliadel) in the Treatment of Malignant Glioma
Seema Nagpal
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
Der-Yang Cho et al.
WORLD NEUROSURGERY (2012)
The kaleidoscope of glucorticoid effects on immune system
Margherita Zen et al.
AUTOIMMUNITY REVIEWS (2011)
Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors
Sara Mariucci et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2011)
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
Robert M. Prins et al.
CLINICAL CANCER RESEARCH (2011)
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights
Agnes E. Coutinho et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
John H. Sampson et al.
NEURO-ONCOLOGY (2011)
Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
Camilo E. Fadul et al.
NEURO-ONCOLOGY (2011)
Conditional Survival of All Primary Brain Tumor Patients by Age, Behavior, and Histology
Kimberly R. Porter et al.
NEUROEPIDEMIOLOGY (2011)
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
M. Weller et al.
NEUROLOGY (2011)
Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
Michael Brada et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
Shannon E. Fogh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
Gregor Dresemann et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
Michael P. Gustafson et al.
NEURO-ONCOLOGY (2010)
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma
Sandeep Kunwar et al.
NEURO-ONCOLOGY (2010)
Low Peripheral Lymphocyte Count Before Focal Radiotherapy Plus Concomitant Temozolomide Predicts Severe Lymphopenia During Malignant Glioma Treatment
Eiichi Ishikawa et al.
NEUROLOGIA MEDICO-CHIRURGICA (2010)
Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma
Robert Owen Dillman et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Efficacy of anti-epileptic drugs in patients with gliomas and seizures
Melanie S. M. van Breemen et al.
JOURNAL OF NEUROLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas
Emmanouil Fokas et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
James F. Curtin et al.
PLOS MEDICINE (2009)
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
Steven De Vleeschouwer et al.
CLINICAL CANCER RESEARCH (2008)
Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials
James F. Curtin et al.
PLOS ONE (2008)
The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas
David E. Gerber et al.
NEURO-ONCOLOGY (2007)
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
R Yamanaka et al.
CLINICAL CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
分享论文
